Molecular interaction fingerprints approaches for GPCR drug discovery.

M. Vass, A.J. Kooistra, T. Ritschel, R. Leurs, I.J.P. de Esch, C. de Graaf

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Protein–ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein–ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein–ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.
Original languageEnglish
Pages (from-to)59-68
JournalCurrent Opinion in Pharmacology
Volume30
DOIs
Publication statusPublished - 2016

Fingerprint

Dermatoglyphics
Drug Discovery
G-Protein-Coupled Receptors
Ligands
Polypharmacology
Binding Sites
Amino Acids

Cite this

Vass, M. ; Kooistra, A.J. ; Ritschel, T. ; Leurs, R. ; de Esch, I.J.P. ; de Graaf, C. / Molecular interaction fingerprints approaches for GPCR drug discovery. In: Current Opinion in Pharmacology. 2016 ; Vol. 30. pp. 59-68.
@article{a455cb8208fd4a68adf4148d57ad4696,
title = "Molecular interaction fingerprints approaches for GPCR drug discovery.",
abstract = "Protein–ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein–ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein–ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.",
author = "M. Vass and A.J. Kooistra and T. Ritschel and R. Leurs and {de Esch}, I.J.P. and {de Graaf}, C.",
year = "2016",
doi = "10.1016/j.coph.2016.07.007",
language = "English",
volume = "30",
pages = "59--68",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",

}

Molecular interaction fingerprints approaches for GPCR drug discovery. / Vass, M.; Kooistra, A.J.; Ritschel, T.; Leurs, R.; de Esch, I.J.P.; de Graaf, C.

In: Current Opinion in Pharmacology, Vol. 30, 2016, p. 59-68.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Molecular interaction fingerprints approaches for GPCR drug discovery.

AU - Vass, M.

AU - Kooistra, A.J.

AU - Ritschel, T.

AU - Leurs, R.

AU - de Esch, I.J.P.

AU - de Graaf, C.

PY - 2016

Y1 - 2016

N2 - Protein–ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein–ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein–ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.

AB - Protein–ligand interaction fingerprints (IFPs) are binary 1D representations of the 3D structure of protein–ligand complexes encoding the presence or absence of specific interactions between the binding pocket amino acids and the ligand. Various implementations of IFPs have been developed and successfully applied for post-processing molecular docking results for G Protein-Coupled Receptor (GPCR) ligand binding mode prediction and virtual ligand screening. Novel interaction fingerprint methods enable structural chemogenomics and polypharmacology predictions by complementing the increasing amount of GPCR structural data. Machine learning methods are increasingly used to derive relationships between bioactivity data and fingerprint descriptors of chemical and structural information of binding sites, ligands, and protein–ligand interactions. Factors that influence the application of IFPs include structure preparation, binding site definition, fingerprint similarity assessment, and data processing and these factors pose challenges as well possibilities to optimize interaction fingerprint methods for GPCR drug discovery.

U2 - 10.1016/j.coph.2016.07.007

DO - 10.1016/j.coph.2016.07.007

M3 - Article

VL - 30

SP - 59

EP - 68

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

ER -